Microbial metabolite delta-valerobetaine is a diet-dependent obesogen – Nature.com
Miranda, J. J. et al. Understanding the rise of cardiometabolic diseases in low- and middle-income countries. Nat. Med. 25, 1667–1679 (2019).
Google Scholar
Wang, Y. et al. Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic. Int. J. Epidemiol. 49, 810–823 (2020).
Google Scholar
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M. & Owen, L. J. Dysbiosis of the gut microbiota in disease. Microb. Ecol. Health Dis. 26, 26191 (2015).
Google Scholar
Rosenbaum, M., Knight, R. & Leibel, R. L. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol. Metab. 26, 493–501 (2015).
Google Scholar
Ignacio, A. et al. Correlation between body mass index and faecal microbiota from children. Clin. Microbiol Infect. 22, 258 e251–e258 (2016).
Gonzalez, F. J., Jiang, C. & Patterson, A. D. An intestinal microbiota-farnesoid x receptor axis modulates metabolic disease. Gastroenterology 151, 845–859 (2016).
Google Scholar
San-Cristobal, R., Navas-Carretero, S., Martinez-Gonzalez, M. A., Ordovas, J. M. & Martinez, J. A. Contribution of macronutrients to obesity: implications for precision nutrition. Nat. Rev. Endocrinol. 16, 305–320 (2020).
Google Scholar
Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H. & Nicholson, J. K. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol. 19, 349–359 (2011).
Google Scholar